Ignite Creation Date:
2024-05-06 @ 3:27 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04633278
Status:
TERMINATED
Last Update Posted:
2024-02-02
First Post:
2020-10-26
Brief Title:
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals